Activated cryptic granulocyte-macrophage colony-stimulating factor autoantibodies in intravenous immunoglobulin preparations

Blood

Volumn 115, Issue 2, 2010, Pages 431-

  Bazin, Renée ^a   St Amour, Isabelle ^a   Laroche, André ^a   Lemieux, Réal ^a  

^a HÉMA QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ANTIGEN ANTIBODY COMPLEX; BLOOD LEVEL; HUMAN; LETTER; PRIORITY JOURNAL; ADULT; AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; BLOOD; BONE MARROW CELL; FEMALE; HEALTH; IMMUNOLOGY; INNATE IMMUNITY; LUNG ALVEOLUS PROTEINOSIS; MALE; METABOLISM; NOTE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADULT; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEALTH; HUMANS; IMMUNITY, INNATE; MALE; MODELS, BIOLOGICAL; MYELOID CELLS; PULMONARY ALVEOLAR PROTEINOSIS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 75649119712     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-08-240309     Document Type: Letter

References (6)

1. Uchida K, Nakata K, Suzuki T, et al. Granulocyte/macrophage-colony- stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood. 2009;113(11):2547-2556.
2. Svenson M, Hansen MB, Ross C, et al. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations. Blood. 1998;91(6):2054-2061.
3. Watanabe M, Uchida K, Nakagaki K, et al. Anti-cytokine autoantibodies are ubiquitous in healthy individuals. FEBS Lett. 2007;581(10):2017-2021.
4. St-Amour I, Laroche A, Bazin R, Lemieux R. Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins. Clin Immunol. 2009;133(1):52-60.
5. Bouvet JP, Stahl D, Rose S, Quan CP, Kazatchkine MD, Kaveri SV. Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents. J Autoimmun. 2001;16(2):163-172.
6. Svenson M, Hansen MB, Bendtzen K. Binding of cytokines to pharmaceutically prepared human immunoglobulin. J Clin Invest. 1993;92(5):2533-2539.